Prime Medicine Inc (NASDAQ: PRME) kicked off on Tuesday, up 11.76% from the previous trading day, before settling in for the closing price of $1.19. Over the past 52 weeks, PRME has traded in a range of $1.11-$8.14.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
While this was happening, its average annual earnings per share was recorded 23.35%. With a float of $51.73 million, this company’s outstanding shares have now reached $131.16 million.
The extent of productivity of a business whose workforce counts for 214 workers is very important to gauge. In terms of profitability, gross margin is 95.87%, operating margin of -496.2%, and the pretax margin is -485.69%.
Prime Medicine Inc (PRME) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Prime Medicine Inc is 60.60%, while institutional ownership is 28.66%. The most recent insider transaction that took place on May 20 ’25, was worth 23,790. In this transaction Chief Business Officer of this company bought 20,000 shares at a rate of $1.19, taking the stock ownership to the 20,000 shares. Before that another transaction happened on May 21 ’25, when Company’s Chief Technical Officer bought 100,000 for $1.13, making the entire transaction worth $113,000. This insider now owns 100,000 shares in total.
Prime Medicine Inc (PRME) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 23.35% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 18.29% during the next five years compared to -124.13% drop over the previous five years of trading.
Prime Medicine Inc (NASDAQ: PRME) Trading Performance Indicators
Take a look at Prime Medicine Inc’s (PRME) current performance indicators. Last quarter, stock had a quick ratio of 4.78. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 45.36.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.66, a number that is poised to hit -0.36 in the next quarter and is forecasted to reach -1.00 in one year’s time.
Technical Analysis of Prime Medicine Inc (PRME)
The latest stats from [Prime Medicine Inc, PRME] show that its last 5-days average volume of 1.32 million was inferior to 1.51 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 48.53%. Additionally, its Average True Range was 0.15.
During the past 100 days, Prime Medicine Inc’s (PRME) raw stochastic average was set at 9.78%, which indicates a significant decrease from 44.90% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 151.26% in the past 14 days, which was higher than the 112.46% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.4770, while its 200-day Moving Average is $2.8376. Now, the first resistance to watch is $1.3860. This is followed by the second major resistance level at $1.4420. The third major resistance level sits at $1.5350. If the price goes on to break the first support level at $1.2370, it is likely to go to the next support level at $1.1440. Assuming the price breaks the second support level, the third support level stands at $1.0880.
Prime Medicine Inc (NASDAQ: PRME) Key Stats
The company with the Market Capitalisation of 174.62 million has total of 131,294K Shares Outstanding. Its annual sales at the moment are 2,980 K in contrast with the sum of -195,880 K annual income. Company’s last quarter sales were recorded 1,450 K and last quarter income was -51,890 K.
